1Szatmary P, Grammatikopoulos T, Cai W, et al. Acute pancreatitis:diagnosis and treatment[J]. Drugs, 2022, 82(12): 1251-1276.
2 王迎芝, 张先进, 杨士彦. 基于Logistic回归分析急性胰腺炎并发持续性器官功能衰竭的因素[J]. 肝胆外科杂志, 2022, 30(5): 365-369.
3Liu X, Jin J, Liu Y, et al. Targeting TSP-1 decreased periodontitis by attenuating extracellular matrix degradation and alveolar bone destruction[J]. Int Immunopharmacol, 2021, 96: 107618.
4 顾立志, 孙虹, 严专. 血浆组织蛋白酶S和血小板反应蛋白-1在感染性休克患者预后评估中的价值[J]. 热带医学杂志, 2019, 19(11): 1413-1416.
5Matsumura K, Hayashi H, Uemura N, et al. Thrombospondin-1 overexpression stimulates loss of Smad4 and accelerates malignant behavior via TGF-β signal activation in pancreatic ductal adenocarcinoma[J]. Transl Oncol, 2022, 26: 101533.
6 罗娟, 闫再宏, 郭文有. NAFLD患者血清炎症因子、T细胞亚群水平及意义[J]. 现代消化及介入诊疗, 2021, 26(2): 243-246.
7 中华医学会外科学分会胰腺外科学组. 中国急性胰腺炎诊治指南(2021)[J]. 中华消化外科杂志, 2021, 20(7): 730-739.
8 王倅旭, 闵瑞雪, 李秀玲, 等. 血钙联合血清6 h乳酸清除率对脓毒症患者病情及预后的评估价值[J]. 贵州医科大学学报, 2022, 47(7): 858-862, 868.
9Buter A, Imrie CW, Carter CR, et al. Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis[J]. Br J Surg, 2002, 89(3): 298-302.
10 Li XY, He C, Zhu Y, et al. Role of gut microbiota on intestinal barrier function in acute pancreatitis[J]. World J Gastroenterol, 2020, 26(18):2187-2193.
11 Garg PK, Singh VP. Organ failure due to systemic injury in acute pancreatitis[J]. Gastroenterology, 2019, 156(7): 2008-2023.
12 李歌, 田霞. 血清hs-CRP PCT RDW和NRBC水平在重症急性胰腺炎患者中的表达水平及意义[J]. 河北医学, 2023, 29(5): 762-767.
13 Gwag T, Reddy Mooli RG, Li D, et al. Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease[J]. JHEP Rep, 2020, 3(1): 100193.
14 Gutierrez LS, Gutierrez J. Thrombospondin 1 in metabolic diseases[J]. Front Endocrinol (Lausanne), 2021, 12: 638536.
15 Erdem N, Chen KT, Qi M, et al. Thrombospondin-1, CD47, and SIRPα display cell-specific molecular signatures in human islets and pancreata[J]. Am J Physiol Endocrinol Metab, 2023, 324(4):E347-E357.
16 Nickel S, Vlaic S, Christ M, et al. Mesenchymal stromal cells mitigate liver damage after extended resection in the pig by modulating thrombospondin-1/TGF-β[J]. NPJ Regen Med, 2021, 6(1): 84-101.
17 Hou Y, Xin Y, Liu S, et al. A biocompatible nanoparticle-based approach to inhibiting renal ischemia reperfusion injury in mice by blocking thrombospondin-1 activity[J]. Am J Transplant, 2022, 22(9):2246-2253.
18 任振光. 血清降钙素原凝血酶敏感蛋白-1及序贯器官衰竭评分对感染性休克患者预后的临床预测价值分析[J]. 实用医技杂志, 2022, 29(6): 605-608.
19 Kumar R, Mickael C, Kassa B, et al. Interstitial macrophage-derived thrombospondin-1 contributes to hypoxia-induced pulmonary hypertension[J]. Cardiovasc Res, 2020, 116(12): 2021-2030.
20 Mi J, Liu Z, Pei S, et al. Mendelian randomization study for the roles of IL-18 and IL-1 receptor antagonist in the development of inflammatory bowel disease[J]. Int Immunopharmacol, 2022, 110:109020.
21 Tahtinen S, Tong AJ, Himmels P, et al. IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines[J]. Nat Immunol, 2022, 23(4): 532-542.
22 Hendrikx T, Walenbergh SM, Jeurissen ML, et al. Plasma IL-1 receptor antagonist levels correlate with the development of non-alcoholic steatohepatitis[J]. Biomark Med, 2015, 9(12): 1301-1309.
23 Bülow Anderberg S, Luther T, Berglund M, et al. Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients[J]. Cytokine, 2021, 138(1): 155389.
24 Vasseur P, Devaure I, Sellier J, et al. High plasma levels of the pro-inflammatory cytokine IL-22 and the anti-inflammatory cytokines IL-10 and IL-1ra in acute pancreatitis[J]. Pancreatology, 2014, 14(6):465-469.